Novel METTL3 Inhibitor Elicits Clinical Activity Across Tumor Types - Targeted Oncology

Retrieved on: 2024-11-26 18:03:44

Tags for this article:

Click the tags to see associated articles and topics

Novel METTL3 Inhibitor Elicits Clinical Activity Across Tumor Types - Targeted Oncology. View article details on hiswai:

Excerpt

... immune pathways, which may contribute to its antitumor effects. 1. “The ability to activate the innate immune system while maintaining tolerability ...

Article found on: www.targetedonc.com

View Original Article